CCND1 and neoplasm: Aberrant activation of NF-κB pathway is observed in a variety of tumor types, which regulates a range of tumorgenic processes, including proliferation, invasion, metastasis and angiogenesis, by transcriptionally activating numerous target genes, such as CCND1, MYC, MMP9 and VEGF in cancer cells30,31.